Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Cost analysis of COPD exacerbations and cardiovascular events in SUMMIT.

Stanford RH, Coutinho AD, Eaddy M, Yue B, Bogart M.

Am J Manag Care. 2019 Nov 1;25(11):e320-e325.

2.

Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs.

Averell CM, Stanford RH, Laliberté F, Wu JW, Germain G, Duh MS.

J Asthma. 2019 Oct 14:1-10. doi: 10.1080/02770903.2019.1663429. [Epub ahead of print]

PMID:
31607180
3.

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol.

Moretz C, Bengtson LG, Sharpsten L, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 4;14:2047-2060. doi: 10.2147/COPD.S213520. eCollection 2019.

4.

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.

Moretz C, Sharpsten L, Bengtson LG, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R.

Int J Chron Obstruct Pulmon Dis. 2019 Aug 1;14:1721-1737. doi: 10.2147/COPD.S204649. eCollection 2019.

5.

The influence of extensive green roofs on rainwater runoff quality: a field-scale study in southwest China.

Liu R, Stanford RL, Deng Y, Liu D, Liu Y, Yu SL.

Environ Sci Pollut Res Int. 2019 Aug 12. doi: 10.1007/s11356-019-06151-5. [Epub ahead of print]

PMID:
31407262
6.

Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.

Bollmeier SG, Seaton TL, Prosser TR, Chou YT, Reckenberg K, Hahn B, Stanford RH, Ray R.

J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):479-488.e1. doi: 10.1016/j.japh.2019.04.017. Epub 2019 May 22.

7.

Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA.

Stanford RH, Parker ED, Reinsch TK, Buikema AR, Blauer-Peterson C.

Respir Med. 2019 Apr;150:1-7. doi: 10.1016/j.rmed.2019.01.019. Epub 2019 Feb 6.

PMID:
30961933
8.

Identifying Predictors of Higher Acute Care Costs for Patients With Traumatic Spinal Cord Injury and Modeling Acute Care Pathway Redesign: A Record Linkage Study.

Vaikuntam BP, Middleton JW, McElduff P, Connelly L, Pearse J, Stanford R, Walsh J, Sharwood LN.

Spine (Phila Pa 1976). 2019 Aug 15;44(16):E974-E983. doi: 10.1097/BRS.0000000000003021.

PMID:
30882757
9.

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.

Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 19;14:343-352. doi: 10.2147/COPD.S184653. eCollection 2019.

10.

SUcceSS, SUrgery for Spinal Stenosis: protocol of a randomised, placebo-controlled trial.

Anderson DB, Ferreira ML, Harris IA, Davis GA, Stanford R, Beard D, Li Q, Jan S, Mobbs RJ, Maher CG, Yong R, Zammit T, Latimer J, Buchbinder R.

BMJ Open. 2019 Feb 13;9(2):e024944. doi: 10.1136/bmjopen-2018-024944.

11.

Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma.

Stanford RH, Averell C, Parker ED, Blauer-Peterson C, Reinsch TK, Buikema AR.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1488-1496.e7. doi: 10.1016/j.jaip.2018.12.021. Epub 2019 Jan 10.

PMID:
30639604
12.

External Validation of a COPD Risk Measure in a Commercial and Medicare Population: The COPD Treatment Ratio.

Stanford RH, Lau MS, Li Y, Stemkowski S.

J Manag Care Spec Pharm. 2019 Jan;25(1):58-69. doi: 10.18553/jmcp.2019.25.1.058.

13.

Emergency and acute care management of traumatic spinal cord injury: a survey of current practice among senior clinicians across Australia.

Sharwood LN, Dhaliwal S, Ball J, Burns B, Flower O, Joseph A, Stanford R, Middleton J.

BMC Emerg Med. 2018 Dec 20;18(1):57. doi: 10.1186/s12873-018-0207-0.

14.

Lumbar spine fusion: what is the evidence?

Harris IA, Traeger A, Stanford R, Maher CG, Buchbinder R.

Intern Med J. 2018 Dec;48(12):1430-1434. doi: 10.1111/imj.14120.

PMID:
30517997
15.

Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting.

Bogart M, Glassberg MB, Reinsch T, Stanford RH.

Respir Med. 2018 Dec;145:138-144. doi: 10.1016/j.rmed.2018.10.013. Epub 2018 Oct 26.

16.

Cross-sectional survey study to examine underuse of twice daily inhaled maintenance therapy among patients with asthma.

Stanford RH, Bell C, Nag A, Johnson PT, Johnson MP, Watkins A.

J Asthma. 2019 Nov;56(11):1172-1181. doi: 10.1080/02770903.2018.1531994. Epub 2018 Nov 5.

PMID:
30395748
17.

Initiation of Triple Therapy with Multiple Inhalers in Chronic Obstructive Pulmonary Disease: An Analysis of Treatment Patterns from a U.S. Retrospective Database Study.

Lane DC, Stemkowski S, Stanford RH, Tao Z.

J Manag Care Spec Pharm. 2018 Nov;24(11):1165-1172. doi: 10.18553/jmcp.2018.24.11.1165.

18.

The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models.

Buikema AR, Brekke L, Anderson A, Koep E, Van Voorhis D, Sharpsten L, Hahn B, Ray R, Stanford RH.

Multidiscip Respir Med. 2018 Oct 11;13:38. doi: 10.1186/s40248-018-0151-6. eCollection 2018.

19.

Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.

Bogart M, Stanford RH, Reinsch T, Hull M, Buikema A, Hulbert E.

Respir Med. 2018 Sep;142:73-80. doi: 10.1016/j.rmed.2018.07.009. Epub 2018 Jul 17.

20.

Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder.

Sansgiry SS, Bhansali A, Serna O, Kamdar M, Fleming M, Abughosh S, Stanford RH.

Curr Med Res Opin. 2019 Feb;35(2):321-328. doi: 10.1080/03007995.2018.1495622. Epub 2018 Jul 31.

PMID:
29962241
21.

Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.

Hahn B, Hull M, Blauer-Peterson C, Buikema AR, Ray R, Stanford RH.

Respir Med. 2018 Jun;139:65-71. doi: 10.1016/j.rmed.2018.04.014. Epub 2018 Apr 22.

23.

The impact of patient education and shared decision making on hospital readmissions for COPD.

Collinsworth AW, Brown RM, James CS, Stanford RH, Alemayehu D, Priest EL.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 24;13:1325-1332. doi: 10.2147/COPD.S154414. eCollection 2018.

24.

Using an internet intervention to support self-management of low back pain in primary care: findings from a randomised controlled feasibility trial (SupportBack).

Geraghty AWA, Stanford R, Stuart B, Little P, Roberts LC, Foster NE, Hill JC, Hay EM, Turner D, Malakan W, Leigh L, Yardley L.

BMJ Open. 2018 Mar 9;8(3):e016768. doi: 10.1136/bmjopen-2017-016768.

25.

Claims-based risk model for first severe COPD exacerbation.

Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Schatz M, Vekeman F, Gauthier-Loiselle M, Merrigan JFP, Duh MS.

Am J Manag Care. 2018 Feb 1;24(2):e45-e53.

26.

A diverse mammal-dominated, footprint assemblage from wetland deposits in the Lower Cretaceous of Maryland.

Stanford R, Lockley MG, Tucker C, Godfrey S, Stanford SM.

Sci Rep. 2018 Jan 31;8(1):741. doi: 10.1038/s41598-017-18619-w.

27.

Barriers and Benefits to the Use of Patient-Reported Outcome Measures in Routine Clinical Care: A Qualitative Study.

Philpot LM, Barnes SA, Brown RM, Austin JA, James CS, Stanford RH, Ebbert JO.

Am J Med Qual. 2018 Jul;33(4):359-364. doi: 10.1177/1062860617745986. Epub 2017 Dec 19.

PMID:
29258323
28.

A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference.

Collison KA, Patel P, Preece AF, Stanford RH, Sharma RK, Feldman G.

COPD. 2018 Feb;15(1):46-50. doi: 10.1080/15412555.2017.1400000. Epub 2017 Dec 11.

PMID:
29227727
29.

Health outcomes and costs of acute traumatic spinal injury in New South Wales, Australia.

Mitchell R, Harvey L, Stanford R, Close J.

Spine J. 2018 Jul;18(7):1172-1179. doi: 10.1016/j.spinee.2017.11.013. Epub 2017 Nov 16.

PMID:
29155343
30.

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada.

Dang-Tan T, Zhang S, Tavares RV, Stutz M, Ismaila AS, Vaillancourt J, Corriveau D, Stanford RH, Lin X, Nadeau GA, Simidchiev A, Parsons D, Sampalis JS.

Can Respir J. 2017;2017:8184915. doi: 10.1155/2017/8184915. Epub 2017 Jun 20.

31.

Evidence for the presence of a bacterial endosymbiont in the pecan scab pathogen Venturia effusa (basyonym: Fusicladium effusum).

Medrano EG, Grauke LJ, Stanford RL, Thompson TE.

J Appl Microbiol. 2017 Aug;123(2):491-497. doi: 10.1111/jam.13503.

PMID:
28561954
32.

Image-Guided Lateral Mass Osteotomy for En Bloc Resection of Cervical Ewing Sarcoma: A Technical Note.

Li JXJ, Phan K, Tran TM, Mobbs RJ, Stanford R.

World Neurosurg. 2017 Aug;104:628-633. doi: 10.1016/j.wneu.2017.05.071. Epub 2017 May 19.

PMID:
28532919
33.

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.

Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;12:997-1008. doi: 10.2147/COPD.S124420. eCollection 2017.

34.

Improving care standards for patients with spinal trauma combining a modified e-Delphi process and stakeholder interviews: a study protocol.

Sharwood LN, Stanford R, Middleton JW, Burns B, Joseph A, Flower O, Rigby O, Ball J, Dhaliwal S.

BMJ Open. 2017 Jan 19;7(1):e012377. doi: 10.1136/bmjopen-2016-012377.

35.

Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.

Tran M, Xiang P, Rascati KL, Stock EM, Godley PJ, Coleman A, Bogart MR, Stanford RH.

J Manag Care Spec Pharm. 2016 Oct;22(10):1186-93. doi: 10.18553/jmcp.2016.22.10.1186.

36.

Eosinophilic Granulomatosis With Polyangiitis Sine Asthma.

Parperis K, Stanford R, Isfahani F, Chebbo A, Chhaya S.

Am J Med Sci. 2016 Aug;352(2):e3. doi: 10.1016/j.amjms.2015.11.013. Epub 2016 May 9. No abstract available.

PMID:
27524228
37.

The effects of early or direct admission to a specialised spinal injury unit on outcomes after acute traumatic spinal cord injury.

Maharaj MM, Stanford RE, Lee BB, Mobbs RJ, Marial O, Schiller M, Toson B.

Spinal Cord. 2017 May;55(5):518-524. doi: 10.1038/sc.2016.117. Epub 2016 Aug 2.

PMID:
27481092
38.

Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China.

Chen Y, Ye L, Stanford RR, Zhang D, Zhang X, Wei W.

Mol Clin Oncol. 2016 May;4(5):749-755. Epub 2016 Mar 7.

39.

Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.

Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Vekeman F, Gauthier-Loiselle M, Duh MS, Merrigan JF, Schatz M.

Ann Am Thorac Soc. 2016 Jul;13(7):1067-75. doi: 10.1513/AnnalsATS.201508-493OC.

PMID:
27070274
40.

The SH3 domain of UNC-89 (obscurin) interacts with paramyosin, a coiled-coil protein, in Caenorhabditis elegans muscle.

Qadota H, Mayans O, Matsunaga Y, McMurry JL, Wilson KJ, Kwon GE, Stanford R, Deehan K, Tinley TL, Ngwa VM, Benian GM.

Mol Biol Cell. 2016 May 15;27(10):1606-20. doi: 10.1091/mbc.E15-09-0675. Epub 2016 Mar 23.

41.

Ureteric obstruction secondary to a paraperitoneal inguinal hernia.

Ahmed S, Stanford R.

Ann R Coll Surg Engl. 2016 Feb;98(2):e16-8. doi: 10.1308/rcsann.2016.0024. Epub 2016 Jan 7.

42.

Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group.

Stanford RH, Nagar S, Lin X, O'Connor RD.

J Manag Care Spec Pharm. 2015 Nov;21(11):1014-9.

43.

A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.

Yun Kirby S, Zhu CQ, Kerwin EM, Stanford RH, Georges G.

COPD. 2016;13(2):167-75. doi: 10.3109/15412555.2015.1057274. Epub 2015 Oct 30.

PMID:
26516724
44.

Using an internet intervention to support self-management of low back pain in primary care: protocol for a randomised controlled feasibility trial (SupportBack).

Geraghty AW, Stanford R, Little P, Roberts L, Foster NE, Hill JC, Hay E, Stuart B, Turner D, Yardley L.

BMJ Open. 2015 Sep 23;5(9):e009524. doi: 10.1136/bmjopen-2015-009524.

45.

Viperin protein expression inhibits the late stage of respiratory syncytial virus morphogenesis.

Jumat MR, Huong TN, Ravi LI, Stanford R, Tan BH, Sugrue RJ.

Antiviral Res. 2015 Feb;114:11-20. doi: 10.1016/j.antiviral.2014.11.007. Epub 2014 Nov 26.

PMID:
25433308
46.

Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.

Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS.

Curr Med Res Opin. 2014 Jul;30(7):1417-25. doi: 10.1185/03007995.2014.908827. Epub 2014 Apr 14.

PMID:
24666139
47.

Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.

Hagiwara M, Delea TE, Stanford RH.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):54-62. doi: 10.2500/aap.2014.35.3720.

PMID:
24433597
48.
49.

The emergency urology 'tool-box': a useful adjunct for the urology trainee?

Chetwood A, Stanford R, Nair R.

BJU Int. 2013 May;111(5):E265. doi: 10.1111/bju.12128_3. No abstract available. Erratum in: BJU Int. 2013 Jun;111(7):E273. Stamford, Rosie [corrected to Stanford, Rosie].

50.

Incidence, circumstances, treatment and outcome of high-level cervical spinal fracture without associated spinal cord injury in New South Wales, Australia over a 12 year period.

Mitchell RJ, Stanford R, McVeigh C, Bell D, Close JC.

Injury. 2014 Jan;45(1):217-22. doi: 10.1016/j.injury.2013.02.024. Epub 2013 Apr 6.

PMID:
23570702

Supplemental Content

Loading ...
Support Center